Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-64396%Free Cash Flow Margin
VS
Market
Sector
Industry
History
$ 1.86Close
$ 1.76 - $ 10.48 52-Week Range
Ticker Information
Ticker
INMBCompany Name
INMUNE BIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQINMUNE BIO INC - Free Cash Flow Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
INMB - FCF % Historical data
| Date | Free Cash Flow | Free Cash Flow Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -32.2M | -64396% | $ 50K |
| 3/31/2025 | $ -32.71M | -65418% | $ 50K |
| 12/31/2024 | $ -33.36M | -238292.86% | $ 14K |
| 9/30/2024 | $ -25.75M | -61307.14% | $ 42K |
| 6/30/2024 | $ -23.03M | -27090.59% | $ 85K |
| 3/31/2024 | $ -18.32M | -13980.92% | $ 131K |
| 12/31/2023 | $ -11.98M | -7729.03% | $ 155K |
| 9/30/2023 | $ -14.27M | -6372.32% | $ 224K |
| 6/30/2023 | $ -13.38M | -4794.62% | $ 279K |
| 3/31/2023 | $ -14.96M | -6008.84% | $ 249K |
Key Performance Insights, Last 5 Years
- INMUNE BIO INC's latest trailing twelve months (TTM) FCF % stands at 0%.
- Over the past 5 years, INMUNE BIO INC's average FCF % has been -51689.68%.
- The median FCF % for INMUNE BIO INC during this period was -15748.07%
- INMUNE BIO INC reached its highest FCF % over the past 5 years at -4794.62%.
- The lowest FCF % recorded by INMUNE BIO INC in the same timeframe -238292.86%
INMUNE BIO INC's FCF % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF % Benchmarks
Similar metrics to Revenues:
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
Definition of Free Cash Flow Margin
[Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.FCF / Revenues
(=) FCF % FCF % for INMUNE BIO INC is calculated as follows: FCF [ $ -6.98M ] / Revenues [ $ 0 ]
(=) FCF % [ 0% ] INMB - Free Cash Flow Margin, Last 5 years
-238292.86%
Minimum
Dec 31, 2024
-4794.62%
Maximum
Jun 30, 2023
-51689.68%
Average
-15748.07%
Median
FCF % Benchmark AnalysisMarket
The chart above depicts the distribution of FCF % for companies in the Total Stock Market. The average FCF % of the companies is 7.87% with a standard deviation of 19.48%.
The following table provides additional summary stats:
FCF % in the Market:
| filtered constituents | 3.18K |
|---|---|
| min | -58.23% |
| max | 68.19% |
| average | 7.87% |
| median | 7.4% |
| std | 19.48% |